Ya’ir Aizenmann
Dalberg Global Development Advisors

Ya’ir Aizenman is a senior consultant with Dalberg Global Development Advisors, where he focuses on the firm’s health care practice. In addition his work with the MDGHA, Ya’ir’s projects at Dalberg have included writing a design and process evaluation of the Pneumococcal AMC, a $1.5B financing initiative to purchase pneumococcal vaccines for low-income countries; helping the US Mission in Haiti develop a balanced scorecard to track its progress in assisting with post-earthquake reconstruction; and developing an analysis for the GAVI Alliance comparing the economics of second-generation vaccine producers and generic drug manufacturers.

Before Dalberg, Ya’ir worked at the Clinton Health Access Initiative (CHAI), where he co-wrote, with Paul Wilson, Value for Money in Malaria Programming: Issues and Opportunities, a CGD working paper examining ways to improve the cost-effectiveness of global malaria efforts. Before joining CHAI, Ya’ir worked for D.E. Shaw, a New York-based investments manager. Ya’ir has an AB in computer science from Harvard University.

Articles by Ya’ir Aizenmann

The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
No Thanks
Thank you for signing up to receive the NextBillion Notes newsletter.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.